StonvexLoading…
StonvexStonvexStonvexCore line items from PKOH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.60B | $1.66B | $1.66B | $1.49B |
Operating Income | $66.30M | $86.60M | $84.10M | $33.40M |
Net Income | $23.80M | $31.80M | $7.80M | $-14.20M |
EPS (Diluted) | $1.70 | $2.40 | $0.62 | $-1.16 |
Total Assets | $1.42B | $1.37B | $1.34B | $1.44B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $44.80M | $53.10M | $54.80M | $58.20M |
Free Cash Flow OCF − CapEx | $2.00M | $3.60M | $25.20M | $-53.50M |
Shares Outstanding | 13.97M | 13.24M | 12.51M | 12.19M |